Le Bonheur enrolls first patient in the country in multi-center PREEMIE trial
Le Bonheur Children’s was the first center in the country to enroll a patient in the PREEMIE trial, a study that is evaluating the safety and efficacy of the Bloom™ Micro Occluder System.
Led at Le Bonheur by Interventional Cardiologist Neil Tailor, MD, the PREEMIE study will investigate the clinical benefit of the device to treat patent ductus arteriosus (PDA) – a birth defect where a small blood vessel near the heart does not close after birth – in premature infants who weigh as little as 600 grams. This patient population has no other approved device on the market.
The Bloom™ Micro Occluder System is intended to streamline treatment in this high-risk patient population, and provide solutions to common procedural challenges, such as flexibility to minimize distortion on the heart and to avoid catheter exchanges.
Interventional Cardiologist Neil Tailor, MD, leads the PREEMIE study at Le Bonheur.
Help us provide the best care for kids.
Le Bonheur Children's Hospital depends on the generosity of friends like you to help us serve 250,000 children each year, regardless of their family’s ability to pay. Every gift helps us improve the lives of children.
Donate Now
